About this trial
This study compares remifentanil infusion versus nicardipine infusion for controlled hypotension during elective nasal surgery. Both agents are standard clinical methods. The study evaluates hemodynamic stability, surgical field quality (Fromme-Boezaart score), tissue perfusion, intraoperative blood loss, surgeon satisfaction, and perioperative adverse effects.
Eligibility criteria
Qualifiers
Age > 18 years
ASA physical status I-II
Scheduled for elective nasal surgery
No known serious cardiovascular, respiratory, renal, or hepatic disease
Disqualifiers
Age < 18 years
ASA III or above
Known serious cardiovascular, respiratory, renal, or hepatic disease
Known allergy to remifentanil or nicardipine
Trial design
Treatments tested in this trial
- Nicardipine
- Remifentanil
Treatment groups
Locations
Sponsors and collaborators
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead sponsor
Dicle University
Sponsor institution